{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:13:47Z","timestamp":1793708027394,"version":"4.6.1"},"reference-count":146,"publisher":"European Respiratory Society (ERS)","issue":"6","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2024,5,8]]},"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>Formerly regarded as a rare disease, bronchiectasis is increasingly recognised. A renewed interest in this disease has led to significant progress in bronchiectasis research. Randomised clinical trials (RCTs) have demonstrated the benefits of airway clearance techniques, inhaled antibiotics and long-term macrolide therapy in bronchiectasis patients. However, the heterogeneity of bronchiectasis remains one of the most challenging aspects of management. Phenotypes and endotypes of bronchiectasis have been identified to help find \u201ctreatable traits\u201d and partially overcome disease complexity. The goals of therapy for bronchiectasis are to reduce the symptom burden, improve quality of life, reduce exacerbations and prevent disease progression. We review the pharmacological and non-pharmacological treatments that can improve mucociliary clearance, reduce airway inflammation and tackle airway infection, the key pathophysiological features of bronchiectasis. There are also promising treatments in development for the management of bronchiectasis, including novel anti-inflammatory therapies. This review provides a critical update on the management of bronchiectasis focusing on treatable traits and recent RCTs.<\/jats:p>","DOI":"10.1183\/13993003.00518-2024","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T11:10:13Z","timestamp":1716462613000},"page":"2400518","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":124,"title":["Bronchiectasis management in adults: state of the art and future directions"],"prefix":"10.1183","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4812-0653","authenticated-orcid":false,"given":"Hayoung","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J.","family":"McShane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-4531","authenticated-orcid":false,"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5514-7868","authenticated-orcid":false,"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"2024102103264986000_63.6.2400518.1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","article-title":"Bronchiectasis","volume":"4","author":"Chalmers","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2024102103264986000_63.6.2400518.2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024102103264986000_63.6.2400518.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10122784"},{"key":"2024102103264986000_63.6.2400518.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01033-2015"},{"key":"2024102103264986000_63.6.2400518.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00194-2019"},{"key":"2024102103264986000_63.6.2400518.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00954-2015"},{"key":"2024102103264986000_63.6.2400518.7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1479972317709649","article-title":"Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013","volume":"14","author":"Weycker","year":"2017","journal-title":"Chron Respir Dis"},{"key":"2024102103264986000_63.6.2400518.8","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02033-2018"},{"key":"2024102103264986000_63.6.2400518.9","doi-asserted-by":"crossref","first-page":"7126","DOI":"10.1038\/s41598-021-86407-8","article-title":"Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities","volume":"11","author":"Choi","year":"2021","journal-title":"Sci Rep"},{"key":"2024102103264986000_63.6.2400518.10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.chest.2023.06.040","article-title":"The economic burden of bronchiectasis: a systematic review","volume":"164","author":"Roberts","year":"2023","journal-title":"Chest"},{"key":"2024102103264986000_63.6.2400518.11","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"2024102103264986000_63.6.2400518.12","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00081-2015"},{"key":"2024102103264986000_63.6.2400518.13","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1016\/S2214-109X(19)30327-4","article-title":"Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry","volume":"7","author":"Dhar","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2024102103264986000_63.6.2400518.14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/resp.14059","article-title":"Characteristics of bronchiectasis in Korea: first data from the Korean Multicentre Bronchiectasis Audit and Research Collaboration registry and comparison with other international registries","volume":"26","author":"Lee","year":"2021","journal-title":"Respirology"},{"key":"2024102103264986000_63.6.2400518.15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034090"},{"key":"2024102103264986000_63.6.2400518.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2019.07.016"},{"key":"2024102103264986000_63.6.2400518.17","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212463"},{"key":"2024102103264986000_63.6.2400518.18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2024102103264986000_63.6.2400518.19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbr.2017.07.014","article-title":"Spanish guidelines on treatment of bronchiectasis in adults","volume":"54","author":"Martinez-Garcia","year":"2018","journal-title":"Arch Bronconeumol"},{"key":"2024102103264986000_63.6.2400518.20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/resp.14479","article-title":"Thoracic Society of Australia and New Zealand (TSANZ) position statement on chronic suppurative lung disease and bronchiectasis in children, adolescents and adults in Australia and New Zealand","volume":"28","author":"Chang","year":"2023","journal-title":"Respirology"},{"key":"2024102103264986000_63.6.2400518.21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/atm.ATM_171_17","article-title":"The Saudi Thoracic Society guidelines for diagnosis and management of noncystic fibrosis bronchiectasis","volume":"12","author":"Al-Jahdali","year":"2017","journal-title":"Ann Thorac Med"},{"key":"2024102103264986000_63.6.2400518.22","first-page":"6","article-title":"Inflammation: a two-edged sword \u2013 the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"2024102103264986000_63.6.2400518.23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0041-1730891","article-title":"Pathophysiology of bronchiectasis","volume":"42","author":"Keir","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"key":"2024102103264986000_63.6.2400518.24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"key":"2024102103264986000_63.6.2400518.25","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb\/4.1.26"},{"key":"2024102103264986000_63.6.2400518.26","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00097014"},{"key":"2024102103264986000_63.6.2400518.27","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.008037"},{"key":"2024102103264986000_63.6.2400518.28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2024102103264986000_63.6.2400518.29","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201309-1575OC"},{"key":"2024102103264986000_63.6.2400518.30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: the E-FACED score","volume":"12","author":"Martinez-Garcia","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2024102103264986000_63.6.2400518.31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1055\/s-0041-1730892","article-title":"Diagnosis and initial investigation of bronchiectasis","volume":"42","author":"Amati","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"key":"2024102103264986000_63.6.2400518.32","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.chest.2016.12.024","article-title":"Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study","volume":"151","author":"De Soyza","year":"2017","journal-title":"Chest"},{"key":"2024102103264986000_63.6.2400518.33","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00176-2022"},{"key":"2024102103264986000_63.6.2400518.34","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23304"},{"key":"2024102103264986000_63.6.2400518.35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2024102103264986000_63.6.2400518.36","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway mucus hyperconcentration in non-cystic fibrosis bronchiectasis","volume":"201","author":"Ramsey","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103264986000_63.6.2400518.37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo7728"},{"key":"2024102103264986000_63.6.2400518.38","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02053-2022"},{"key":"2024102103264986000_63.6.2400518.39","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00055509"},{"key":"2024102103264986000_63.6.2400518.40","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00426-2021"},{"key":"2024102103264986000_63.6.2400518.41","doi-asserted-by":"publisher","DOI":"10.1159\/000085363"},{"key":"2024102103264986000_63.6.2400518.42","doi-asserted-by":"publisher","DOI":"10.1177\/1479972306075483"},{"key":"2024102103264986000_63.6.2400518.43","doi-asserted-by":"crossref","first-page":"e1836","DOI":"10.1002\/pri.1836","article-title":"Bubble-positive expiratory pressure device and sputum clearance in bronchiectasis: a randomised cross-over study","volume":"25","author":"Santos","year":"2020","journal-title":"Physiother Res Int"},{"key":"2024102103264986000_63.6.2400518.44","first-page":"103","article-title":"The efficacy of Flutter and active cycle of breathing techniques in patients with bronchiectasis: a prospective, randomized, comparative study","volume":"19","author":"Uzmezoglu","year":"2018","journal-title":"Turk Thorac J"},{"key":"2024102103264986000_63.6.2400518.45","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01926-2017"},{"key":"2024102103264986000_63.6.2400518.46","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2357"},{"key":"2024102103264986000_63.6.2400518.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.05.006"},{"key":"2024102103264986000_63.6.2400518.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.07.019"},{"key":"2024102103264986000_63.6.2400518.49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jamp.2017.1443","article-title":"Impact of hypertonic saline solutions on sputum expectoration and their safety profile in patients with bronchiectasis: a randomized crossover trial","volume":"31","author":"Herrero-Cortina","year":"2018","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"2024102103264986000_63.6.2400518.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.12.021"},{"key":"2024102103264986000_63.6.2400518.51","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.5.1329"},{"key":"2024102103264986000_63.6.2400518.52","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1763"},{"key":"2024102103264986000_63.6.2400518.53","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-205587"},{"key":"2024102103264986000_63.6.2400518.54","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1164\/rccm.201910-1972OC","article-title":"Relationship between symptoms, exacerbations, and treatment response in bronchiectasis","volume":"201","author":"Gao","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103264986000_63.6.2400518.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.08.004"},{"key":"2024102103264986000_63.6.2400518.56","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-15-44"},{"key":"2024102103264986000_63.6.2400518.57","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02138-2019"},{"key":"2024102103264986000_63.6.2400518.58","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00741-2023"},{"key":"2024102103264986000_63.6.2400518.59","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/s12931-022-02202-7","article-title":"Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis","volume":"23","author":"Choi","year":"2022","journal-title":"Respir Res"},{"key":"2024102103264986000_63.6.2400518.60","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0487OC"},{"key":"2024102103264986000_63.6.2400518.61","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201506-333OC"},{"key":"2024102103264986000_63.6.2400518.62","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01953-2017"},{"key":"2024102103264986000_63.6.2400518.63","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/qjmed\/hcaa120","article-title":"Role of Stenotrophomonas maltophilia isolation in patients with non-CF bronchiectasis","volume":"113","author":"Marra","year":"2020","journal-title":"QJM"},{"key":"2024102103264986000_63.6.2400518.64","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201706-426OC"},{"key":"2024102103264986000_63.6.2400518.65","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2213-2600(20)30557-9","article-title":"The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study","volume":"9","author":"Dicker","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024102103264986000_63.6.2400518.66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183553"},{"key":"2024102103264986000_63.6.2400518.67","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201210-1937OC"},{"key":"2024102103264986000_63.6.2400518.68","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01289-7"},{"key":"2024102103264986000_63.6.2400518.69","doi-asserted-by":"publisher","DOI":"10.1038\/nature23480"},{"key":"2024102103264986000_63.6.2400518.70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03157-4"},{"key":"2024102103264986000_63.6.2400518.71","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00851-2016"},{"key":"2024102103264986000_63.6.2400518.72","doi-asserted-by":"crossref","first-page":"1479973119872513","DOI":"10.1177\/1479973119872513","article-title":"Eradication of Pseudomonas aeruginosa with inhaled colistin in adults with non-cystic fibrosis bronchiectasis","volume":"16","author":"Blanco-Aparicio","year":"2019","journal-title":"Chron Respir Dis"},{"key":"2024102103264986000_63.6.2400518.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.11.018"},{"key":"2024102103264986000_63.6.2400518.74","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0178-2023"},{"key":"2024102103264986000_63.6.2400518.75","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201311-395FR"},{"key":"2024102103264986000_63.6.2400518.76","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00071312"},{"key":"2024102103264986000_63.6.2400518.77","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02052-2017"},{"key":"2024102103264986000_63.6.2400518.78","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02053-2017"},{"key":"2024102103264986000_63.6.2400518.79","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203207"},{"key":"2024102103264986000_63.6.2400518.80","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-2600(18)30427-2","article-title":"Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials","volume":"7","author":"Haworth","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102103264986000_63.6.2400518.81","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102103264986000_63.6.2400518.82","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.2.9910086"},{"key":"2024102103264986000_63.6.2400518.83","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chest.2022.07.007","article-title":"A double-blind randomized placebo-controlled phase 3 trial of tobramycin inhalation solution in adults with bronchiectasis with Pseudomonas aeruginosa infection","volume":"163","author":"Guan","year":"2023","journal-title":"Chest"},{"key":"2024102103264986000_63.6.2400518.84","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12931-022-02243-y","article-title":"Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis","volume":"23","author":"Terpstra","year":"2022","journal-title":"Respir Res"},{"key":"2024102103264986000_63.6.2400518.85","doi-asserted-by":"crossref","first-page":"2001451","DOI":"10.1183\/13993003.01451-2020","article-title":"Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study","volume":"57","author":"Loebinger","year":"2021","journal-title":"Eur Respir J"},{"key":"2024102103264986000_63.6.2400518.86","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201005-0756OC"},{"key":"2024102103264986000_63.6.2400518.87","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2208OC"},{"key":"2024102103264986000_63.6.2400518.88","doi-asserted-by":"crossref","unstructured":"Cordeiro R , Choi H , Haworth CS , et al. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: updated systematic review and meta-analysis. Chest 2024; in press [https:\/\/doi.org\/10.1016\/j.chest.2024.01.045]. doi:10.1016\/j.chest.2024.01.045","DOI":"10.1016\/j.chest.2024.01.045"},{"key":"2024102103264986000_63.6.2400518.89","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2021.RCT4267"},{"key":"2024102103264986000_63.6.2400518.90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201809-1651OC","article-title":"Airway bacterial load and inhaled antibiotic response in bronchiectasis","volume":"200","author":"Sibila","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103264986000_63.6.2400518.91","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00110-2020"},{"key":"2024102103264986000_63.6.2400518.92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.21037\/atm-22-3437","article-title":"Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention","volume":"11","author":"Choi","year":"2023","journal-title":"Ann Transl Med"},{"key":"2024102103264986000_63.6.2400518.93","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00608-2020"},{"key":"2024102103264986000_63.6.2400518.94","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201605-1027OC"},{"key":"2024102103264986000_63.6.2400518.95","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2024102103264986000_63.6.2400518.96","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N Engl J Med"},{"key":"2024102103264986000_63.6.2400518.97","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00303-2019"},{"key":"2024102103264986000_63.6.2400518.98","doi-asserted-by":"crossref","unstructured":"Yang B , Yun H , Seong C , et al. Association between sputum myeloperoxidase concentration and acute exacerbation of bronchiectasis. Pulmonology 2023; in press [https:\/\/doi.org\/10.1016\/j.pulmoe.2023.10.006]. doi:10.1016\/j.pulmoe.2023.10.006","DOI":"10.1016\/j.pulmoe.2023.10.006"},{"key":"2024102103264986000_63.6.2400518.99","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201601-044OC"},{"key":"2024102103264986000_63.6.2400518.100","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.chest.2020.12.020","article-title":"Impact of bronchiectasis on incident nontuberculous mycobacterial pulmonary disease: a 10-year national cohort study","volume":"159","author":"Yang","year":"2021","journal-title":"Chest"},{"key":"2024102103264986000_63.6.2400518.101","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60953-2"},{"key":"2024102103264986000_63.6.2400518.102","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2290"},{"key":"2024102103264986000_63.6.2400518.103","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.1937"},{"key":"2024102103264986000_63.6.2400518.104","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"Chalmers","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2024102103264986000_63.6.2400518.105","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"Rogers","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102103264986000_63.6.2400518.106","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1235"},{"key":"2024102103264986000_63.6.2400518.107","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02189-16"},{"key":"2024102103264986000_63.6.2400518.108","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cyto.2017.08.005","article-title":"The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis","volume":"99","author":"Tsikrika","year":"2017","journal-title":"Cytokine"},{"key":"2024102103264986000_63.6.2400518.109","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of eosinophilic bronchiectasis: a European multicohort study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103264986000_63.6.2400518.110","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1164\/rccm.202303-0499OC","article-title":"Inflammatory molecular endotypes in bronchiectasis: a European multicenter cohort study","volume":"208","author":"Choi","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103264986000_63.6.2400518.111","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00453-2020"},{"key":"2024102103264986000_63.6.2400518.112","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2005.12.002"},{"key":"2024102103264986000_63.6.2400518.113","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0180"},{"key":"2024102103264986000_63.6.2400518.114","doi-asserted-by":"crossref","first-page":"106127","DOI":"10.1016\/j.rmed.2020.106127","article-title":"Role of inhaled corticosteroids in reducing exacerbations in bronchiectasis patients with blood eosinophilia pooled post-hoc analysis of 2 randomized clinical trials","volume":"172","author":"Martinez-Garcia","year":"2020","journal-title":"Respir Med"},{"key":"2024102103264986000_63.6.2400518.115","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01333-2019"},{"key":"2024102103264986000_63.6.2400518.116","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.anai.2020.11.014","article-title":"Efficacy of type 2-targeted biologics in patients with asthma and bronchiectasis","volume":"126","author":"Kudlaty","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2024102103264986000_63.6.2400518.117","doi-asserted-by":"crossref","first-page":"106491","DOI":"10.1016\/j.rmed.2021.106491","article-title":"Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: a real-world retrospective pilot study","volume":"185","author":"Crimi","year":"2021","journal-title":"Respir Med"},{"key":"2024102103264986000_63.6.2400518.118","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S196200"},{"key":"2024102103264986000_63.6.2400518.119","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/biomedicines9070772","article-title":"T2-high endotype and response to biological treatments in patients with bronchiectasis","volume":"9","author":"Oriano","year":"2021","journal-title":"Biomedicines"},{"key":"2024102103264986000_63.6.2400518.120","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.arbres.2020.06.005","article-title":"Repeteability of circulating eosinophil measures and inhaled corticosteroids effect in bronchiectasis. A post hoc analysis of a randomized clinical trial","volume":"56","author":"Martinez-Garcia","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"2024102103264986000_63.6.2400518.121","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.rmed.2011.01.015","article-title":"Elevated peripheral airway nitric oxide in bronchiectasis reflects disease severity","volume":"105","author":"Shoemark","year":"2011","journal-title":"Respir Med"},{"key":"2024102103264986000_63.6.2400518.122","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01888-2015"},{"key":"2024102103264986000_63.6.2400518.123","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.rmed.2018.10.031","article-title":"A comprehensive approach to lung function in bronchiectasis","volume":"145","author":"Radovanovic","year":"2018","journal-title":"Respir Med"},{"key":"2024102103264986000_63.6.2400518.124","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103264986000_63.6.2400518.125","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00051-2017"},{"key":"2024102103264986000_63.6.2400518.126","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12931-019-1272-y","article-title":"Development and initial validation of the bronchiectasis exacerbation and symptom tool (BEST)","volume":"21","author":"Artaraz","year":"2020","journal-title":"Respir Res"},{"key":"2024102103264986000_63.6.2400518.127","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04004"},{"key":"2024102103264986000_63.6.2400518.128","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1164\/rccm.202102-0461OC","article-title":"A randomized clinical trial of antimicrobial duration for cystic fibrosis pulmonary exacerbation treatment","volume":"204","author":"Goss","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102103264986000_63.6.2400518.129","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04388-2020"},{"key":"2024102103264986000_63.6.2400518.130","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03157-2020"},{"key":"2024102103264986000_63.6.2400518.131","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/cpt.1053","article-title":"Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure-dependent reduction in neutrophil elastase activity in healthy subjects","volume":"104","author":"Palmer","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"2024102103264986000_63.6.2400518.132","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00633-2022"},{"key":"2024102103264986000_63.6.2400518.133","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024102103264986000_63.6.2400518.134","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-571ST"},{"key":"2024102103264986000_63.6.2400518.135","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00061-2024"},{"key":"2024102103264986000_63.6.2400518.136","first-page":"222","article-title":"Recommendations for aetiological diagnosis of bronchiectasis","volume":"22","year":"2016","journal-title":"Rev Port Pneumol"},{"key":"2024102103264986000_63.6.2400518.137","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2018.PA2678"},{"key":"2024102103264986000_63.6.2400518.138","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.congress-2021.PA2062"},{"key":"2024102103264986000_63.6.2400518.139","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ccm.2021.11.005","article-title":"Bronchiectasis and chronic obstructive pulmonary disease overlap syndrome","volume":"43","author":"Sobala","year":"2022","journal-title":"Clin Chest Med"},{"key":"2024102103264986000_63.6.2400518.140","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01862-2015"},{"key":"2024102103264986000_63.6.2400518.141","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.jaip.2019.02.026","article-title":"Prevalence and clinical implications of chronic rhinosinusitis in people with bronchiectasis: a systematic review","volume":"7","author":"Handley","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102103264986000_63.6.2400518.142","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.04.006"},{"key":"2024102103264986000_63.6.2400518.143","doi-asserted-by":"crossref","first-page":"17562848211062801","DOI":"10.1177\/17562848211062801","article-title":"Gastro-oesophageal reflux disease increases healthcare use and medical costs in patients with bronchiectasis: a Korean nationwide population-based study","volume":"14","author":"Yoon","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"2024102103264986000_63.6.2400518.144","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12890-021-01675-4","article-title":"Prevalence of depression and its associated factors in bronchiectasis: findings from KMBARC registry","volume":"21","author":"Lee","year":"2021","journal-title":"BMC Pulm Med"},{"key":"2024102103264986000_63.6.2400518.145","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11136-012-0188-5","article-title":"Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life","volume":"22","author":"Olveira","year":"2013","journal-title":"Qual Life Res"},{"key":"2024102103264986000_63.6.2400518.146","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-208188"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00518-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T02:20:30Z","timestamp":1740363630000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00518-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":146,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,28]]},"published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1183\/13993003.00518-2024"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00518-2024","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]}}}